Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
236
236 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- SHR-2173Phase 25 trials
Guangdong Hengrui Pharmaceutical Co., Ltd · Generalized Myasthenia Gravis, Active Lupus Nephritis, Primary IgA Nephropathy
- zamtocabtagene autoleucelMB-CART2019.1Phase 25 trials
Miltenyi Biomedicine GmbH · CAR T Cell Therapy, Mantle Cell Lymphoma (MCL), Multiple Sclerosis
- Descartes-08Phase 24 trials
Cartesian Therapeutics · Myasthenia Gravis, Generalized, Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)
- EVO756Phase 24 trials
Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis
- ML-007C-MAPhase 24 trials
MapLight Therapeutics · Psychosis Associated With Alzheimer's Disease, Schizophrenia
- SevasemtenPhase 24 trials
Edgewise Therapeutics, Inc. · Becker Muscular Dystrophy, Duchenne Muscular Dystrophy
- SPN-817BIS-001ER, Huperzine APhase 24 trials
Supernus Pharmaceuticals, Inc. · Focal Onset Seizures, Focal Impaired Awareness Seizures, Epilepsy
- Allogeneic umbilical cord mesenchymal stem cellsPhase 23 trials
Ever Supreme Bio Technology Co., Ltd. · COVID-19 Infection, Multiple Sclerosis, ST Elevation Myocardial Infarction
- BrogidirsenNS-089, NCNP-02Phase 23 trials
NS Pharma, Inc. · Duchenne Muscular Dystrophy, Exon 44, DMD
- Human Dopaminergic Progenitor CellsNouvNeu001Phase 23 trials
iRegene Therapeutics Co., Ltd. · Parkinson Disease, Parkinson Disease (PD)
- iPSChuman allogeneic induced pluripotent stem cell -derived dopaminergic neural progenitor cell, Allogeneic Human Induced Pluripotent Stem Cell -Derived Motor Neuron Progenitor CellsPhase 23 trials
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. · Spinal Cord Injury, Safety, Efficacy
- LY4065967Phase 23 trials
Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee
- NMD670Phase 23 trials
NMD Pharma A/S · Myasthenia Gravis, Myasthenia Gravis, MuSK, Charcot-Marie-Tooth Disease
- Zugocabtagene geleucelCTX112Phase 23 trials
CRISPR Therapeutics AG · B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy
- [18F]F-AraGPET tracer, 2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguaninePhase 22 trials
CellSight Technologies, Inc. · Alzheimer Disease (AD), Covid19, SARS-CoV Infection
- AB-1005Phase 22 trials
AskBio Inc · PARKINSON DISEASE (Disorder), Parkinson Disease
- ALT001Phase 22 trials
Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. · Ischemic Stroke in the Sequelae Stage, Amyotrophic Lateral Sclerosis (ALS)
- AMDX-2011PPhase 22 trials
Amydis Inc. · Cerebral Amyloid Angiopathy, Alzheimer Disease
- Autologous HB-adMSCsPhase 22 trials
Hope Biosciences LLC · Traumatic Brain Injury, Relapsing Remitting Multiple Sclerosis (RRMS), Multiple Sclerosis
- BMB-101Phase 22 trials
Bright Minds Biosciences Pty Ltd · Absence Epilepsy, Jeavons Syndrome, Dravet Syndrome
- BMN 351Phase 22 trials
BioMarin · Duchenne Muscular Dystrophy (DMD), Duchenne Muscular Dystrophy
- BMS-986368CC-97489Phase 22 trials
Bristol Myers Squibb · Agitation, Alzheimer Disease, Multiple Sclerosis Spasticity
- C-CAR168Phase 22 trials
AbelZeta Inc. · Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE), Autoimmune Diseases
- CNMAu8gold nanocrystalsPhase 22 trials
Clene Nanomedicine · Amyotrophic Lateral Sclerosis, Multiple Sclerosis
- CT1812Study Drug ActivePhase 22 trials
Cognition Therapeutics · Early Alzheimer's Disease, Dementia With Lewy Bodies
- DNL151BIIB122Phase 22 trials
Denali Therapeutics Inc. · Parkinson Disease
- ENTR-601-44Phase 22 trials
Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)
- ENTR-601-45Phase 22 trials
Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)
- Foralumab NasalPhase 22 trials
Tiziana Life Sciences LTD · ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis, ALS
- GV101Phase 22 trials
Graviton Bioscience Corporation · Friedreich's Ataxia, Weight Management
- HBI-002Phase 22 trials
Hillhurst Biopharmaceuticals, Inc. · Parkinson Disease, Anemia, Sickle Cell
- KDS2010Phase 22 trials
NeuroBiogen Co., Ltd · Overweight, Obesity, Obese Patients
- matched to VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- mivelsiranALN-APPPhase 22 trials
Alnylam Pharmaceuticals · Cerebral Amyloid Angiopathy, Down Syndrome-Associated Alzheimer's Disease (DS-AD)
- NE3107bezisterimPhase 22 trials
BioVie Inc. · Long COVID, Parkinsons Disease (PD)
- ONO-2020Phase 22 trials
Ono Pharmaceutical Co., Ltd. · Agitation Associated With Alzheimer's Disease Dementia, Alzheimer Disease
- ORX750Phase 22 trials
Centessa Pharmaceuticals (UK) Limited · Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
- RO7568282Phase 22 trials
Roche (Genentech) · Parkinson's Disease, Alzheimer's Disease
- SAT-3247Phase 22 trials
Satellos Bioscience, Inc. · Duchenne Muscular Dystrophy, Duchenne, DMD
- SNK01Phase 22 trials
NKGen Biotech, Inc. · Alzheimer Disease, Moderate Alzheimer Disease
- VHB937Phase 22 trials
Novartis · Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease
- VIM0423Phase 22 trials
Vima Therapeutics · PARKINSON DISEASE (Disorder), Dystonia
- VTX3232Phase 22 trials
Zomagen Biosciences Ltd. · Idiopathic Parkinson Disease, Obesity
- VutiglabridinHSG4112Phase 22 trials
Glaceum · Knee Osteoarthritis (Knee OA), Parkinson Disease
- VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- WVE-N531Phase 22 trials
Wave Life Sciences USA, Inc. · Duchenne Muscular Dystrophy
- ABBV-1758Phase 21 trial
AbbVie · Alzheimer's Disease
- ABBV-916Phase 21 trial
AbbVie · Alzheimer's Disease (AD)
- ABS-1230Phase 21 trial
Actio Biosciences, Inc. · KCNT1-Related Epilepsy
- ALZN002autologous DCs pulsed with E22W mutant peptidePhase 21 trial
Alzamend Neuro, Inc. · Alzheimer Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.